サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1428453

DNAシーケンシングの世界市場レポート 2024

DNA Sequencing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
DNAシーケンシングの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

DNAシーケンシングの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には15.7%の年間複合成長率（CAGR）で244億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、次世代シーケンシング（NGS）の進歩、ポイントオブケアシークエンシングの実装、集団ゲノミクスにおける取り組み、人工知能（AI）と機械学習の統合、および精密医療の。予測期間中に予想される主要な動向には、単一細胞シーケンシングの進歩、エピジェネティクスとトランスクリプトミクスへの焦点、リキッドバイオプシー技術の開発、倫理とプライバシーに関する考慮事項、ナノテクノロジーの導入が含まれます。

DNAシーケンシング市場の予想される成長は、がんの罹患率の増加によって促進されると予想されます。さまざまな臓器に影響を与える制御されていない細胞増殖を特徴とするがんは、世界的に罹患率と死亡率の主な原因となっています。 DNAシーケンシングは、遺伝子変異の特定、腫瘍生物学の理解、治療決定のガイドにおいて極めて重要な役割を果たし、最終的にがん治療の成果を向上させます。注目すべきことに、マクミランがんサポートは2022年10月に、がん患者の数は2020年には300万人だったが、2025年までに350万人、2030年までに400万人、2040年までに530万人に増加すると予測していると報告しました。その結果、がんの罹患率は増大しています。 DNAシーケンシング市場の成長を推進する重要な要素です。

個別化医療に対する需要の高まりにより、DNAシーケンシング市場の拡大が見込まれています。遺伝子、環境、ライフスタイルの個人差を考慮した革新的なアプローチである個別化医療は、医療とヘルスケアの分野で注目を集めています。個人の遺伝子構造に合わせて治療を調整することに重点が置かれているため、特定の遺伝子変異を特定し、治療の決定を導くためのDNAシーケンシングテクノロジーの必要性が高まっています。 2022年、The Personalized Medicine Coalitionは、2021年に新たに承認された新規分子実体（NME）の35%が個別化医療であると報告しました。したがって、個別化医療に対する需要の高まりは、DNAシーケンシング市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のDNAシーケンシング市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 機器
  • 消耗品
  • サービス
  • 世界のDNAシーケンシング市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 第三世代DNAシーケンシング
  • 次世代シーケンス
  • サンガー配列決定
  • 世界のDNAシーケンシング市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 診断
  • バイオマーカーとがん
  • リプロダクティブ・ヘルス
  • 個別化医療
  • 法医学
  • その他の用途
  • 世界のDNAシーケンシング市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院とヘルスケア機関
  • 学術および研究機関
  • 製薬会社およびバイオテクノロジー会社
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のDNAシーケンシング市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のDNAシーケンシング市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • DNAシーケンシング市場の競合情勢
  • DNAシーケンシング市場の企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA

第31章 その他の大手および革新的な企業

  • Siemens Healthineers AG
  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • BGI Genomics
  • Myriad Genetics Inc.
  • Natera Inc.
  • 10x Genomics Inc.
  • GenScript Biotech Corporation
  • Novogene Corporation
  • Twist Bioscience
  • Genewiz LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14298

DNA sequencing involves determining the precise order or sequence of nucleotides (adenine, cytosine, guanine, and thymine) in a DNA molecule. This molecular biology and genetics technique is fundamental, enabling scientists to decipher the genetic code embedded within an organism's DNA.

The primary components of DNA sequencing are instruments, consumables, and services. Instruments, defined as mechanical tools or implements, particularly those used for delicate or precise operations, are employed in DNA sequencing to automate and execute the various steps involved in sequencing DNA samples. Technologies such as third-generation DNA sequencing, next-generation sequencing, and Sanger sequencing are applied in diagnostics, biomarkers and cancer research, reproductive health studies, personalized medicine initiatives, forensics, and other scientific domains. This technology is utilized by a diverse range of entities, including hospitals and healthcare organizations, academic and research institutions, as well as pharmaceutical and biotechnology companies.

The DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides DNA sequencing market statistics, including the DNA sequencing industry's global market size, regional shares, competitors with an DNA sequencing market share, detailed DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the DNA sequencing industry. This DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The DNA sequencing market size has grown rapidly in recent years. It will grow from $11.84 billion in 2023 to $13.68 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The historical period's growth can be ascribed to factors such as the Human Genome Project, reductions in costs, the expansion of biomedical research, the adoption of clinical diagnostics, and the needs of pharmaceutical research and development.

The DNA sequencing market size is expected to see rapid growth in the next few years. It will grow to $24.49 billion in 2028 at a compound annual growth rate (CAGR) of 15.7%. The anticipated growth in the forecast period can be attributed to advancements in next-generation sequencing (NGS), the implementation of point-of-care sequencing, initiatives in population genomics, integration of artificial intelligence (AI) and machine learning, and the adoption of precision medicine. Key trends expected in the forecast period encompass progress in single-cell sequencing, a focus on epigenetics and transcriptomics, the development of liquid biopsy techniques, considerations related to ethics and privacy, and the incorporation of nanotechnology.

The anticipated growth in the DNA sequencing market is expected to be driven by the rising prevalence of cancer. Cancer, characterized by uncontrolled cell growth impacting various organs, is a leading cause of morbidity and mortality globally. DNA sequencing plays a pivotal role in identifying genetic mutations, comprehending tumor biology, and guiding treatment decisions, ultimately enhancing outcomes in cancer care. Notably, Macmillan Cancer Support reported in October 2022 that the number of individuals with cancer was 3 million in 2020 and is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the escalating prevalence of cancer is a key factor propelling the growth of the DNA sequencing market.

The growing demand for personalized medicine is poised to drive the expansion of the DNA sequencing market. Personalized medicine, an innovative approach considering individual variations in genes, environments, and lifestyles, has gained prominence in medical treatment and healthcare. The emphasis on tailoring treatments to an individual's genetic makeup has led to an increased need for DNA sequencing technologies to identify specific genetic variations and guide treatment decisions. In 2022, The Personalized Medicine Coalition reported that personalized medicines accounted for 35% of newly approved new molecular entities (NMEs) in 2021. Therefore, the escalating demand for personalized medicine is a significant factor fueling the growth of the DNA sequencing market.

An emerging trend gaining traction in the DNA sequencing market is the progress in single-cell DNA sequencing technologies. Leading companies in the market are embracing innovative technologies to maintain their competitive positions. For example, in May 2023, Mission Bio Inc., a biotechnology company based in the US, introduced Tapestri v3, an advanced version of its high-throughput single-cell DNA and multi-omics analysis platform. Tapestri v3 incorporates breakthrough improvements in chemistry, significantly enhancing the detection of rare cells across various applications. Its improved cell capture capabilities allow researchers to identify previously undetectable single cells, providing a deeper understanding of diseases. This enhanced technology is particularly promising for applications such as measurable residual disease (MRD) assessment in cancer, where Tapestri v3 enables the detection of relapse-driving clones that were previously overlooked. Additionally, it offers advantages for developers of cell and gene therapy by enabling quality assessment at the single-cell level.

Major players in the DNA sequencing market are directing their efforts towards developing innovative solutions, including production-scale sequencers. These advanced DNA sequencing machines are designed for large-scale and high-throughput sequencing, facilitating the efficient processing of significant volumes of genetic material in research, clinical, or industrial settings. For instance, in September 2022, Illumina, Inc., a US-based biotechnology company, launched the 'NovaSeq X Series,' a new production-scale sequencer capable of sequencing more than 20,000 genomes per year with the highest levels of accuracy. This sustainable high-throughput sequencer achieves a 90% reduction in packaging, a 50% reduction in plastic waste, and eliminates the need for dry ice shipments, enhancing global access to genomic medicine and demonstrating a commitment to environmental responsibility.

In August 2021, ProPhase Labs Inc., a US-based next-generation biotech, genomics, and diagnostics company, completed the acquisition of Nebula Genomics for $14.6 million. Through this acquisition, ProPhase Labs aims to integrate Nebula's whole-genome sequencing services with its existing clinical diagnostic testing services, enhancing its capabilities and offerings in genetic testing. Nebula Genomics is a US-based company specializing in whole-genome sequencing services.

Major companies operating in the DNA sequencing market report are F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics, Myriad Genetics Inc., Natera Inc., 10x Genomics Inc., GenScript Biotech Corporation, Novogene Corporation, Twist Bioscience, Genewiz LLC, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., LI-COR Inc., MGI Tech Co. Ltd., Zymo Research Corporation, Igenomix, Codex DNA, GenapSys Inc., SeqOnce Biosciences Inc.

North America was the largest region in the DNA sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the DNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The DNA sequencing market consists of revenues earned by entities by providing bioinformatics and data analysis software and sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA sequencing market also includes sales of DNA sequencing kits, sequencing reagents, and laboratory equipment used in providing DNA sequencing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Instruments; Consumables; Services
  • 2) By Technology: Third Generation DNA Sequencing; Next-Generation Sequencing; Sanger Sequencing
  • 3) By Application: Diagnostics; Biomarkers And Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
  • 1) By End User: Hospitals And Healthcare Organizations; Academics And Research Institutions; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA Sequencing Market Characteristics

3. DNA Sequencing Market Trends And Strategies

4. DNA Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global DNA Sequencing Market Size and Growth

  • 5.1. Global DNA Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global DNA Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global DNA Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. DNA Sequencing Market Segmentation

  • 6.1. Global DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Consumables
  • Services
  • 6.2. Global DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Third Generation DNA Sequencing
  • Next-Generation Sequencing
  • Sanger Sequencing
  • 6.3. Global DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Biomarkers And Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
  • 6.4. Global DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Healthcare Organizations
  • Academics And Research Institutions
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. DNA Sequencing Market Regional And Country Analysis

  • 7.1. Global DNA Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global DNA Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific DNA Sequencing Market

  • 8.1. Asia-Pacific DNA Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China DNA Sequencing Market

  • 9.1. China DNA Sequencing Market Overview
  • 9.2. China DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India DNA Sequencing Market

  • 10.1. India DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan DNA Sequencing Market

  • 11.1. Japan DNA Sequencing Market Overview
  • 11.2. Japan DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia DNA Sequencing Market

  • 12.1. Australia DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia DNA Sequencing Market

  • 13.1. Indonesia DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea DNA Sequencing Market

  • 14.1. South Korea DNA Sequencing Market Overview
  • 14.2. South Korea DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe DNA Sequencing Market

  • 15.1. Western Europe DNA Sequencing Market Overview
  • 15.2. Western Europe DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK DNA Sequencing Market

  • 16.1. UK DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany DNA Sequencing Market

  • 17.1. Germany DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France DNA Sequencing Market

  • 18.1. France DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy DNA Sequencing Market

  • 19.1. Italy DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain DNA Sequencing Market

  • 20.1. Spain DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe DNA Sequencing Market

  • 21.1. Eastern Europe DNA Sequencing Market Overview
  • 21.2. Eastern Europe DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia DNA Sequencing Market

  • 22.1. Russia DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America DNA Sequencing Market

  • 23.1. North America DNA Sequencing Market Overview
  • 23.2. North America DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA DNA Sequencing Market

  • 24.1. USA DNA Sequencing Market Overview
  • 24.2. USA DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada DNA Sequencing Market

  • 25.1. Canada DNA Sequencing Market Overview
  • 25.2. Canada DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America DNA Sequencing Market

  • 26.1. South America DNA Sequencing Market Overview
  • 26.2. South America DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil DNA Sequencing Market

  • 27.1. Brazil DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East DNA Sequencing Market

  • 28.1. Middle East DNA Sequencing Market Overview
  • 28.2. Middle East DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa DNA Sequencing Market

  • 29.1. Africa DNA Sequencing Market Overview
  • 29.2. Africa DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. DNA Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. DNA Sequencing Market Competitive Landscape
  • 30.2. DNA Sequencing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merck KGaA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. DNA Sequencing Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Eurofins Scientific SE
  • 31.3. Agilent Technologies Inc.
  • 31.4. Illumina Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. QIAGEN N.V.
  • 31.8. BGI Genomics
  • 31.9. Myriad Genetics Inc.
  • 31.10. Natera Inc.
  • 31.11. 10x Genomics Inc.
  • 31.12. GenScript Biotech Corporation
  • 31.13. Novogene Corporation
  • 31.14. Twist Bioscience
  • 31.15. Genewiz LLC

32. Global DNA Sequencing Market Competitive Benchmarking

33. Global DNA Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The DNA Sequencing Market

35. DNA Sequencing Market Future Outlook and Potential Analysis

  • 35.1 DNA Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 DNA Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 DNA Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer